Part D Price Controls: House Bill Flags Issue As Health Reform Moves Ahead
This article was originally published in The Pink Sheet Daily
Executive Summary
A group of House Democrats is attempting to generate support for HHS drug price negotiations in Medicare Part D despite the fact that health care reform legislation is advancing without it.